Paratek Pharma - Trending Stock


  • 100% technical buy signals.
  • 15 new highs and up 56.28% in the last month.
  • 137.08% gain in the last year.

The Barchart Chart of the Day belongs to the biopharmaceutical company Paratek Pharmaceuticals (Nasdaq: PRTK).

Readers are always asking me how to find stocks that are just beginning to trend before everyone else discovers them. One of the best ways is to look at Barchart's Strong Volume Gains preformatted screener. It identifies stocks that have had significant increases in both volume and price over the past 5 days. Today it identified 100 stock that fitted that criteria. I sorted that list by the most frequent number of new highs in the last month then used the Flipchart feature to review the chart for consistent price appreciation. Since the Trend Spotter signaled a buy in 5/19 the stock gained 34.43%.

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris.

The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions, and contract with Biomedical Advanced Research and Development Authority to support the development of NUZYRA for the treatment of pulmonary anthrax. It also has license agreement with Tetraphase Pharmaceuticals, Inc. to develop, import, and sell the XERAVATM product, which is used for the treatment of complicated intra-abdominal infections caused by bacteria. The company was founded in 1996 and is headquartered in Boston, Massachusetts. 

1 2
View single page >> |

Disclosure: I/we have no positions in any stocks mentioned, but may initiate a long position in PRTK over the next 72 hours.

Disclaimer: The Barchart Chart of the Day highlights stocks ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.
IB Trading 1 week ago Member's comment

Good stock pick.